4-D (psychedelic)

4-D
Clinical data
Other namesMescaline-D3; 4-Trideuteromethoxy-3,5-methoxyphenethylamine; 4-Trideuteromescaline
Routes of
administration		Oral[1]
Drug classSerotonergic psychedelic; Hallucinogen
ATC code
  • None
Pharmacokinetic data
Duration of action12 hours[1]
Identifiers
  • 1-[3,5-dimethoxy-4-(2H3)methoxyphenyl]propan-2-amine
CAS Number
ChemSpider
UNII
Chemical and physical data
FormulaC11H14D3NO3
Molar mass214.278 g·mol−1
3D model (JSmol)
  • [2H]C([2H])([2H])OC1=C(OC)C=C(CCN)C=C1OC
  • InChI=1S/C11H17NO3/c1-13-9-6-8(4-5-12)7-10(14-2)11(9)15-3/h6-7H,4-5,12H2,1-3H3/i3D3 Y
  • Key:RHCSKNNOAZULRK-HPRDVNIFSA-N Y
 NY (what is this?)  (verify)

4-D, also known as 4-trideuteromethoxy-3,5-methoxyphenethylamine or as 4-trideuteromescaline, is a lesser-known psychedelic drug of the scaline family. It is one of the few drugs that bears deuterium. It is a deuterated analog of mescaline. It may be prepared either as a sulfate salt or a hydrochloride salt. 4-D was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage is listed as approximately 200–400 mg for the sulfate salt, and 178–356 mg for the hydrochloride salt. 4-D lasts for approximately 12 hours. It causes closed-eye visuals, mild open-eye visuals, color distortion, and mydriasis.[1] Very little data exists about the pharmacological properties, metabolism, and toxicity of 4-D.

See also

References

  1. ^ a b c Shulgin, Alexander; Shulgin, Ann (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.